Temporary suspension of sorafenib by adverse effects is associated with longer survival in patients with hepatocellular carcinoma

Saved in:

Bibliographic Details
Published in	Journal of hepatology Vol. 66; no. 1; p. S448
Main Authors	Rodríguez-Escaja, C, de Jorge Turrión, M.A, García, A.C, Díaz, E.R, González-Diéguez, M.L, Álvarez-Navascués, C, Cadahía-Rodrigo, V, Rodríguez, M, Varela, M
Format	Journal Article
Language	English
Published	2017
Subjects	Gastroenterology and Hepatology
Online Access	Get full text

Loading…

More Information
ISSN:	0168-8278
DOI:	10.1016/S0168-8278(17)31272-2